AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with acute myeloid leukemia ...

The 10-minute procedure identified signs of acute myeloid leukaemia (AML) returning in patients before it showed in blood ...

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukaemia (AML) by helping ...

Patients with a rare and aggressive type of blood cancer could soon have their chances of survival doubled as a ...

For months, college student Breeze Hunter, 22, felt pressure and pain in her head. “I had a lot of fluid in my ears, which ...

A novel drug combination targeting LSD1 and GSK3 shows promise in treating acute myeloid leukemia by promoting cell ...

A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.

Researchers sought to determine whether MSD HSCT or auto-HSCT would have advantages over chemotherapy in post-remission treatment for patients with AML.

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.